Morphine Induces Desensitization of Insulin Receptor Signaling

University of Vermont, Burlington, Vermont, United States
Molecular and Cellular Biology (Impact Factor: 4.78). 10/2003; 23(17):6255-66. DOI: 10.1128/MCB.23.17.6255-6266.2003
Source: PubMed


Morphine analgesia is mediated principally by the micro -opioid receptor (MOR). Since morphine and other opiates have been shown to influence glucose homeostasis, we investigated the hypothesis of direct cross talk between the MOR and the insulin receptor (IR) signaling cascades. We show that prolonged morphine exposure of cell lines expressing endogenous or transfected MOR, IR, and the insulin substrate 1 (IRS-1) protein specifically desensitizes IR signaling to Akt and ERK cascades. Morphine caused serine phosphorylation of the IR and impaired the formation of the signaling complex among the IR, Shc, and Grb2. Morphine also resulted in IRS-1 phosphorylation at serine 612 and reduced tyrosine phosphorylation at the YMXM p85-binding motifs, weakening the association of the IRS-1/p85 phosphatidylinositol 3-kinase complex. However, the IRS-1/Grb2 complex was unaffected by chronic morphine treatment. These results suggest that morphine attenuates IR signaling to Akt by disrupting the IRS-1-p85 interaction but inhibits signaling to ERK by disruption of the complex among the IR, Shc, and Grb2. Finally, we show that systemic morphine induced IRS-1 phosphorylation at Ser612 in the hypothalamus and hippocampus of wild type, but not MOR knockout, mice. Our results demonstrate that opiates can inhibit insulin signaling through direct cross talk between the downstream signaling pathways of the MOR and the IR.

Download full-text


Available from: Chris Evans, Jun 14, 2014
  • Source
    • "It is generally thought that receptor desensitization is relevant to receptor phosphorylation and subsequent internalization and down-regulation. [D-Pen2, 5]enkephalin (DPDPE)-induced homologous desensitization of the DOR was significantly attenuated by mutation of the primary phosphorylation site Ser363 to alanine9, 13, and heterologous desensitization was suggested to correlate with heterologous receptor phosphorylation20. DOR undergoes down-regulation after chronic selective agonist exposure, for different agonists the magnitude and time-course of receptor down-regulation varied21, 22, 23, nevertheless, all recent studies favor the idea that reduction of active opioid receptors from the cell surface would potentiate their desensitization. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To define the effect of adenosine A(1) receptor (A(1)R) on delta opioid receptor (DOR)-mediated signal transduction. CHO cells stably expressing HA-tagged A(1)R and DOR-CFP fusion protein were used. The localization of receptors was observed using confocal microscope. DOR-mediated inhibition of adenylyl cyclase was measured using cyclic AMP assay. Western blots were employed to detect the phosphorylation of Akt and the DOR. The effect of A(1)R agonist N(6)-cyclohexyladenosine (CHA) on DOR down-regulation was assessed using radioligand binding assay. CHA 1 micromol/L time-dependently attenuated DOR agonist [D-Pen(2,5)]enkephalin (DPDPE)-induced inhibition of intracellular cAMP accumulation with a t(1/2)=2.56 (2.09-3.31) h. Pretreatment with 1 micromol/L CHA for 24 h caused a right shift of the dose-response curve of DPDPE-mediated inhibition of cAMP accumulation, with a significant increase in EC(50) but no change in E(max). Pretreatment with 1 micromol/L CHA for 1 h also induced a significant attenuation of DPDPE-stimulated phosphorylation of Akt. Moreover, CHA time-dependently phosphorylated DOR (Ser363), and this effect was inhibited by A(1)R antagonist 1,3-Dipropyl-8-cyclopentylxanthine (DPCPX) but not by DOR antagonist naloxone. However, CHA failed to produce the down-regulation of DOR, as neither receptor affinity (K(d)) nor receptor density (B(max)) of DOR showed significant change after chronic CHA exposure. Activation of A(1)R by its agonist caused heterologous desensitization of DOR-mediated inhibition of intracellular cAMP accumulation and phosphorylation of Akt. Activation of A(1)R by its agonist also induced heterologous phosphorylation but not down-regulation of DOR.
    Preview · Article · Jul 2010 · Acta Pharmacologica Sinica
  • Source
    • "We also observed that IL-1␤ interferes by the same mechanism with signaling of another neurotrophic factor NT-3 that under the experimental conditions exerted its action primarily through TrkC activation (manuscript in preparation). Scaffolding proteins are also critically involved in the regulation of insulin and IGF-1 signaling in both neurons and non-neural, peripheral tissues (Garcia-Galloway et al., 2003; Li et al., 2003; Venters et al., 2000; Zick, 2001). In neurons, the wide-ranging nature of regulation at the level of the docking proteins, such as IRS-1, is indicated by the observation that interference at the docking site is not restricted to the effect of IL-1␤ on neurotrophin signaling in cerebral cortical cells. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The expression of IL-1 is elevated in the CNS in diverse neurodegenerative disorders, including Alzheimer's disease. The hypothesis was tested that IL-1 beta renders neurons vulnerable to degeneration by interfering with BDNF-induced neuroprotection. In trophic support-deprived neurons, IL-1 beta compromised the PI3-K/Akt pathway-mediated protection by BDNF and suppressed Akt activation. The effect was specific as in addition to Akt, the activation of MAPK/ERK, but not PLC gamma, was decreased. Activation of CREB, a target of these signaling pathways, was severely depressed by IL-1 beta. As the cytokine did not influence TrkB receptor and PLC gamma activation, IL-1 beta might have interfered with BDNF signaling at the docking step conveying activation to the PI3-K/Akt and Ras/MAPK pathways. Indeed, IL-1 beta suppressed the activation of the respective scaffolding proteins IRS-1 and Shc; this effect might involve ceramide generation. IL-1-induced interference with BDNF neuroprotection and signal transduction was corrected, in part, by ceramide production inhibitors and mimicked by the cell-permeable C2-ceramide. These results suggest that IL-1 beta places neurons at risk by interfering with BDNF signaling involving a ceramide-associated mechanism.
    Full-text · Article · Oct 2008 · Neurobiology of aging
  • Source
    • "The modulation of MAPK pathways can be via mechanisms that either do, or do not, involve transactivation of growth factor signaling pathways (Prenzel et al. 1999; Korzh et al. 2008). For example, signaling via MOR leads to desensitization of insulin receptor signaling which inhibits MAPK activation of the extracellular signal-regulated kinase (ERK) (Li et al. 2003); while, the opioid agonist etorphine activates ERK in a manner independent of a receptor tyrosine kinase (Korzh et al. 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Opiate drugs, such as codeine, morphine, and heroin, are powerful analgesics, but also are used as drugs of abuse because of their psychogenic properties. Many studies have shown that opiates impact on cellular proliferation in the adult and developing brain, although anatomical pathologies are lacking in in utero exposed infants and opioid knockout mice. Recent research has defined a context-dependent role for the opioid system in neurogenesis in the adult hippocampus with exercise. Opioids have been shown to interact with proliferating cells of the postnatal subventricular zone of the lateral ventricles. The subventricular zone is also a region of adult neurogenesis, a fact that was not well established at the time this earlier research was conducted. Although a relationship between opioids and fetal neurogenesis has yet to be firmly established, many studies have implicated the opioid system in this process. One common factor that links neurogenesis in adult, postnatal, and fetal structures is the involvement of neuronal progenitor cells of the astrocytic lineage. It is therefore of interest that opioids have been consistently shown to impact upon astrocytic proliferation. It is the intention of this paper to review the literature that has established a role for the opioid system in neurogenesis in vivo in fetal, postnatal, and adult animals and to examine the links of opioids to modulation of astrocytic proliferation.
    Full-text · Article · Oct 2008 · Journal of Neurochemistry
Show more